SDZNYCongressional Stock Trades
Sandoz Group AG
Drug Manufacturers - Specialty & Generic
Congressional stock trades in Sandoz Group AG (SDZNY) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
1
Politicians Trading
1
Last Traded
Mar 24, 2025
Price History
About Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company has a strategic collaboration with Shanghai Henlius Biotech, Inc. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.
1 members of Congress have disclosed 1 trades in Sandoz Group AG (SDZNY). Most active: George Whitesides (1).
Across all disclosures, members of Congress reported 0 purchases and 1 sales of Sandoz Group AG (SDZNY). The most recent trade was on Mar 24, 2025.
George Whitesides disclosed selling Sandoz Group AG (SDZNY) on Mar 24, 2025, valued at $1,001 - $15,000.
From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.